Search
Tarsus Pharmaceuticals Inc
TARSAdd to Watchlist
63.160USD
+0.610+0.98%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.69BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Tarsus Pharmaceuticals Inc is 9.11, ranking 3 out of 157 in the Pharmaceuticals industry. The average price target is 88.00, with a high of 100.00 and a low of 51.00.
Analyst Rating
Based on
9
analysts
Strong Buy
Current Rating
93.375
Target Price
+47.84%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Tarsus Pharmaceuticals Inc
TARS
9
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Tarsus Pharmaceuticals Inc's expected revenue for the next quarter?
Tarsus Pharmaceuticals Inc's expected revenue is 167.36M.
What is Tarsus Pharmaceuticals Inc's price target?
Analysts forecast that Tarsus Pharmaceuticals Inc's price target is USD 88.00, with the highest forecast at USD 100.00 and the lowest forecast at USD 51.00.
How have Tarsus Pharmaceuticals IncTARS's recent earnings per share performed?
The market expectation was USD -0.16, while Tarsus Pharmaceuticals IncTARS's earnings per share (EPS) for the previous quarter was USD -0.20. EPS for the next quarter is expected at USD -0.26.
What is the analyst rating for Tarsus Pharmaceuticals Inc?
Based on the ratings of Tarsus Pharmaceuticals Inc's stock from 9 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
